A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1998
10/08/1998	WO1998043966A1 Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors
10/08/1998	WO1998043965A1 Thiodepsipeptides for combating endoparasites and a method for producing the same
10/08/1998	WO1998043963A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998	WO1998043960A1 Substituted 3-cyano quinolines
10/08/1998	WO1998043959A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
10/08/1998	WO1998043956A1 1,4-substituted cyclic amine derivatives
10/08/1998	WO1998043954A1 Leukotriene a4 hydrolaze inhibitors
10/08/1998	WO1998043950A1 Antipicornaviral compouds, compositions containing them, and methods for their use
10/08/1998	WO1998043948A1 Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides
10/08/1998	WO1998043947A1 Nitro-benzamide useful as anti-arrhythmic agent
10/08/1998	WO1998043945A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
10/08/1998	WO1998043942A1 Novel compounds, their use and preparation
10/08/1998	WO1998043673A1 Solvent system for enhanced penetration of pharmaceutical compounds
10/08/1998	WO1998043667A1 Methods and compositions for treating inflammatory bowel disease
10/08/1998	WO1998043661A1 Use of substances having oxytocin activity for preparation of medicaments for wound healing
10/08/1998	WO1998043660A1 Use of substances having oxytocin activity for preparation of medicaments for the treatment of affective pain syndromes
10/08/1998	WO1998043654A1 Non-aqueous colonic purgative formulations
10/08/1998	WO1998043653A1 Interpenetrating polymer networks for sequestration of bile acids
10/08/1998	WO1998043652A1 Boron carbohydrate complexes and uses thereof
10/08/1998	WO1998043650A1 A method and a tobramycin aerosol formulation for treatment, prevention and containment of tuberculosis
10/08/1998	WO1998043649A2 Age production inhibitory composition comprising a maillard reaction inhibitor and vitamin b¿6?
10/08/1998	WO1998043648A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia
10/08/1998	WO1998043647A1 Regulation of amyloid precursor protein (app) expression by estrogenic compounds
10/08/1998	WO1998043646A1 New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders
10/08/1998	WO1998043645A1 Inhibitors for the formation of glycosylated protein denaturation products
10/08/1998	WO1998043644A1 Formulations and methods to treat and prevent equine protozoal myeloencephalitis
10/08/1998	WO1998043642A1 Treatment for pulmonary fibrosis
10/08/1998	WO1998043641A1 Pharmaceutical, cosmetic and/or food composition with antioxidant properties
10/08/1998	WO1998043640A1 Benzocycloheptathiophene compounds
10/08/1998	WO1998043639A1 Methods of treating bone loss
10/08/1998	WO1998043637A1 Peroxynitrite decomposition catalyst
10/08/1998	WO1998043636A1 Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
10/08/1998	WO1998043635A1 Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
10/08/1998	WO1998043634A1 A method for improving the weight gain and feed conversion efficiency of swine
10/08/1998	WO1998043633A1 Buffered compositions containing a local anaesthetic and used as an anti-inflammatory
10/08/1998	WO1998043632A1 Protein kinase inhibitor
10/08/1998	WO1998043631A1 Mixture of primary fatty acids obtained from sugar cane wax
10/08/1998	WO1998043630A1 Means of ascertaining an individual's risk profile for atherosclerotic disease
10/08/1998	WO1998043629A1 Anti-inflammatory medicament containing farnesyl protein transferase inhibitor, its preparation and use
10/08/1998	WO1998043627A1 Preventives for ischemic heart diseases
10/08/1998	WO1998043626A1 Preventives for reconstriction
10/08/1998	WO1998043625A1 Use of amantadine for treatment of hepatitis c
10/08/1998	WO1998043624A1 Diabetes remedies
10/08/1998	WO1998043623A1 Antirheumatic agents
10/08/1998	WO1998043622A1 Use of inhibitors of undecaprenol kinase to inhibit cell wall biosynthesis
10/08/1998	WO1998043621A1 Nitrosylation to inactivate apoptotic enzymes
10/08/1998	WO1998043619A2 Method of local anesthesia
10/08/1998	WO1998043618A2 Use of cytoskeletal inhibitors for the prevention of restenosis
10/08/1998	WO1998043617A2 Nutritional composition for improvements in cell energetics
10/08/1998	WO1998043614A1 Drug preparations for treating sexual dysfunction
10/08/1998	WO1998043612A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma
10/08/1998	WO1998043611A1 Diffusional implantable delivery system
10/08/1998	WO1998043607A1 Slimming cosmetic compositions
10/08/1998	WO1998043601A1 Pharmaceutical composition, containing medium-chain fatty acids as active ingredients, for dental caries and periodontal disease
10/08/1998	WO1998043555A1 Intravesical drug delivery system
10/08/1998	WO1998043554A1 Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device
10/08/1998	WO1998043493A1 Pet food composition
10/08/1998	WO1998043484A1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
10/08/1998	WO1998043479A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES
10/08/1998	WO1998043478A1 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/08/1998	WO1998030558A3 Tricyclic compounds useful for inhibition of farnesyl protein transferase
10/08/1998	WO1998028268A3 CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS
10/08/1998	WO1998022104A3 Treatment of neurodegenerative conditions with nimesulide
10/08/1998	WO1998020124A3 Diabetes-mediating proteins and therapeutic uses thereof
10/08/1998	WO1998020027A3 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
10/08/1998	WO1998018429A3 A method for lowering plasma levels of lipoprotein(a)
10/08/1998	WO1998017231A3 Treatment and delivery of hydroxychloroquine
10/08/1998	DE19713768A1 Preparation of betulinic acid for use as anti-cancer and anti-HIV agent
10/08/1998	DE19713626A1 Neue Thiodepsipeptide zur Bekämpfung von Endoparasiten und ein einfaches Verfahren zu ihrer Herstellung New Thiodepsipeptide for controlling endoparasites and a simple method for their preparation
10/08/1998	DE19713543A1 Bakterielle Plasmide Bacterial plasmids
10/08/1998	DE19712633A1 Stimulation of interleukin, especially IL-6, production
10/08/1998	CA2293359A1 Pharmaceutical, cosmetic and/or food composition with antioxidant properties
10/08/1998	CA2289541A1 Antipicornaviral compouds, compositions containing them, and methods for their use
10/08/1998	CA2287298A1 Tetracyclical derivatives from pyrimidine
10/08/1998	CA2286893A1 76 kda, 32 kda, and 50 kda helicobacter polypeptides and corresponding polynucleotide molecules
10/08/1998	CA2286367A1 Pyrolopyrrolone derivatives
10/08/1998	CA2286306A1 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/08/1998	CA2285923A1 Methods and compositions for treating inflammatory bowel disease
10/08/1998	CA2285903A1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same
10/08/1998	CA2285625A1 Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
10/08/1998	CA2285591A1 Intravesical drug delivery system
10/08/1998	CA2285567A1 Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors
10/08/1998	CA2285452A1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
10/08/1998	CA2285434A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia
10/08/1998	CA2285374A1 Preventives for reconstriction
10/08/1998	CA2285372A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998	CA2285368A1 Solvent system for enhanced penetration of pharmaceutical compounds
10/08/1998	CA2285367A1 Preventives for ischemic heart diseases
10/08/1998	CA2285360A1 Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides
10/08/1998	CA2285350A1 Treatment for pulmonary fibrosis
10/08/1998	CA2285320A1 Pyrimidinone-1,3-oxathiolane derivatives with antiviral activity
10/08/1998	CA2285316A1 Therapeutic agent for diabetes mellitus
10/08/1998	CA2285292A1 Use of amantadine for treatment of hepatitis c
10/08/1998	CA2285241A1 Substituted 3-cyano quinolines
10/08/1998	CA2285215A1 Antirheumatic agents
10/08/1998	CA2285197A1 Nitro-benzamide useful as anti-arrhythmic agent
10/08/1998	CA2285181A1 Drug preparations for treating sexual dysfunction
10/08/1998	CA2285091A1 Means of ascertaining an individual's risk profile for atherosclerotic disease
10/08/1998	CA2284940A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma
10/08/1998	CA2284811A1 Pyrimidopyrimidine compounds

1 ... 6597 6598 6599 6600 6601 6602 6603 6604 6605 6606 6607 6608 6609 6610 6611 6612 6613 6614 6615 6616 6617 ... 7860